ALX ONCOLOGY HOLDINGS INC

For the period ended Mar 31, 2024. Filed May 9, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 9, 2024

ALXO$1.29+11.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts)

	March 31,	December 31,
	2024	2023
Assets
Current assets:
Cash and cash equivalents	$14,041	$22,406
Short-term investments	143,396	160,330
Prepaid expenses and other current assets	10,427	5,923
Total current assets	167,864	188,659
Property and equipment, net	3,441	3,589
Long-term investments	27,049	35,411
Other assets	14,296	14,894
Total assets	$212,650	$242,553
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$6,227	$8,591
Payable and accrued liabilities due to related party	375	543
Accrued expenses and other current liabilities	25,626	26,867
Total current liabilities	32,228	36,001
Term loan, non-current	9,703	9,639
Other non-current liabilities	6,524	7,201
Total liabilities	48,455	52,841
Commitments and contingencies (Note 11)
Stockholders’ equity
Common stock, $0.001 par value; 1,000,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 50,277,193 and 49,951,989 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	50	50
Additional paid-in capital	685,970	675,678
Accumulated other comprehensive loss	28	256
Accumulated deficit	(521,853)	(486,272)
Total stockholders’ equity	164,195	189,712
Total liabilities and stockholders’ equity	$212,650	$242,553

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.